Continuing Education Activity

Aseptic meningitis is an inflammatory condition of the meninges characterized by cerebrospinal fluid pleocytosis and negative bacterial cultures. Although generally considered a benign illness, it encompasses a wide range of etiologies and clinical manifestations, which vary depending on the underlying cause and the patient's immune status. Accurate diagnosis and appropriate management require careful evaluation and collaboration among members of an interprofessional care team.

This activity examines the diverse causes and presentations of aseptic meningitis, highlighting the importance of an interprofessional approach to care. Participants strengthen their diagnostic reasoning, expand their understanding of the condition's complexities, and refine their management strategies. By applying this knowledge, clinicians enhance patient safety and improve outcomes in individuals presenting with aseptic meningitis.

Objectives:

• Differentiate between various etiologies of aseptic meningitis, considering the unique features associated with viral, bacterial, and noninfectious causes.
• Implement effective screening methods using appropriate diagnostic tests and criteria to promptly identify aseptic meningitis in patients with compatible clinical presentations.
• Apply evidence-based interventions tailored to the specific etiology of aseptic meningitis.
• Collaborate with an interprofessional healthcare team to optimize diagnosis, treatment, and monitoring.

Introduction

Aseptic meningitis is defined as inflammation of the meninges, the protective membranes covering the brain and spinal cord. This condition is characterized by negative cerebrospinal fluid (CSF) pleocytosis with a negative Gram stain and sterile bacterial cultures. Diagnosis is based on the presence of CSF pleocytosis, indicated by a CSF white blood cell (WBC) count greater than 5 cells/mm³.[1][2][3] Clinical manifestations vary based on the underlying cause and the patient's immune status. Individuals with impaired humoral immunity, including neonates and individuals with agammaglobulinemia, are particularly vulnerable to severe outcomes in cases of aseptic meningitis.[1][4][5]

Etiology

The syndrome is most commonly associated with infectious causes such as mycobacteria, fungi, spirochetes, parameningeal infections, and viruses—notably enteroviruses, herpes simplex virus type 2 (HSV-2), and West Nile virus. Noninfectious causes include medications, especially nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics such as trimethoprim-sulfamethoxazole; malignancies, and connective tissue disorders.[1][3][4][6][7] Despite advances in diagnostic methods, the underlying cause is identified in only 30% to 65% of cases.[8] Instances in which no etiology is determined are classified as idiopathic.[1]

Nonpolio enteroviruses, such as enteric cytopathic human orphan viruses and coxsackieviruses, are the most frequent cause of aseptic meningitis across all age groups, accounting for at least 50% of cases, particularly in children.[9][10] HSV-2 is a notable cause in adults and is associated with recurrent meningitis.[9] Varicella-zoster virus (VZV) and human herpesvirus-6 occur more commonly in immunocompromised adults and children, respectively.[9][10] Less common viral causes include Epstein-Barr virus, mumps virus, measles virus, arboviruses (eg, West Nile virus), influenza virus, and lymphocytic choriomeningitis virus, the latter being more prevalent in unvaccinated and immunocompromised populations.[4][8][11]

Bacterial, fungal, and parasitic infections are less common causes of aseptic meningitis compared to viral infections. Bacterial sources may include partially treated meningitis, parameningeal infections (eg, epidural abscess and mastoiditis), Mycoplasma pneumoniae, endocarditis, Mycobacterium tuberculosis, Treponema pallidum, and leptospirosis. Fungal pathogens associated with aseptic meningitis include Candida species, Cryptococcus neoformans, Histoplasma capsulatum, Coccidioides immitis, and Blastomyces dermatitidis. Parasitic causes of aseptic meningitis include Toxoplasma gondii, Naegleria fowleri, neurocysticercosis (Taenia solium), trichinosis (Trichinella spiralis), and Hartmannella species.[2][12]

Noninfectious causes of aseptic meningitis can be broadly categorized into 3 main groups:[1] 

• Systemic diseases involving meningeal inflammation, such as neurosarcoidosis, Behçet disease, Sjögren syndrome, systemic lupus erythematosus, and granulomatosis with polyangiitis.
• Drug-induced aseptic meningitis is most commonly associated with NSAIDs, antibiotics (sulfamides, penicillins), intravenous immunoglobulin (IVIG), and monoclonal antibodies.
• Neoplastic meningitis, which may result from metastasis of solid tumors or hematologic malignancies such as lymphoma/leukemia.

Rarely, aseptic meningitis has been reported following certain vaccinations, including those for measles, mumps, rubella (MMR); varicella; yellow fever; rabies; pertussis; and influenza.[13][14][15] Recent reports have suggested its occurrence even after the meningococcal vaccination.[16]

Epidemiology

The precise annual incidence of aseptic meningitis remains uncertain due to underreporting.[12] The condition can occur at any age but is more common in children, particularly those younger than 15 years, with a peak incidence in infants younger than 90 days.[17] In adults, the median age of onset is around 33 years.[4][9] Hospitalization rates are consistently higher in males than in females, with pediatric males experiencing about 1.5 times greater risk.[17] A seasonal pattern is observed, with most cases presenting in summer and early autumn, paralleling the peak incidence of enteroviral infections. In adults, the most frequently identified pathogens include enteroviruses, HSV-2, and VZV.[9][12][17][18] Epidemiologic studies have demonstrated higher rates among children of Maori and Pacific ethnicity and those from lower socioeconomic backgrounds, demonstrating disparities in diagnosis and care.[17]

In the United States, the overall incidence of aseptic meningitis is estimated at 11 cases per 100,000 people annually, with a rate of 7.5 per 100,000 in adults, and it is approximately 3 times more common in males than females, without a specific age or racial predilection.[4] Aseptic meningitis accounts for an estimated 26,000 to 42,000 hospitalizations annually in the United States.[4] European studies report an incidence rate of 70 per 100,000 among children younger than 1 year, 5.2 per 100,000 among children aged 1 to 14 years, and 7.6 per 100,000 in adults.[12] 

In a study conducted in South Korea, the incidence of aseptic meningitis among children showed a relatively even distribution across age groups. However, higher rates were noted in children younger than 1 year and in children aged 4 to 7 years. The male-to-female ratio in this cohort was approximately 2:1.[18] An epidemiological study from New Zealand reported a median annual hospitalization rate of 18.4 per 100,000 among children younger than 15 years, with peaks reaching 56.4 per 100,000 during epidemic years. Notably, rates declined significantly during the COVID-19 pandemic, likely reflecting the impact of public health measures.[17]

Pathophysiology

The pathophysiology of aseptic meningitis is characterized by inflammation of the meninges in the absence of detectable bacterial or fungal infection within the CSF. Key mechanisms underlying the pathophysiology include:

• Viral invasion: Viruses enter the body via the respiratory or gastrointestinal tract and disseminate hematogenously to the central nervous system (CNS), triggering an inflammatory response characterized by CSF pleocytosis (elevated WBC count), increased protein, and normal glucose.[9]

• Immune response: The host immune system reacts to viral antigens within the CNS, leading to the release of proinflammatory cytokines (eg, interleukin-1, interleukin-6, and tumor necrosis factor-α) and lymphocytic infiltration of the meninges. These processes mediate meningeal inflammation and the clinical symptoms of meningitis.[19] Notably, immune checkpoint inhibitors, such as ipilimumab or pembrolizumab, can induce a similar mechanism due to dysregulated T-cell activation and subsequent CNS-directed immune responses, resulting in lymphocytic pleocytosis and elevated CSF protein in the absence of infection.[20]

• Drug-induced aseptic meningitis: This condition may arise from direct meningeal irritation (eg, following intrathecal drug administration) or from an immunologic hypersensitivity reaction to systemically administered drugs. The latter is often mediated by type III or IV hypersensitivity reaction, leading to meningeal inflammation without infection.[21]

• Autoinflammatory diseases: Rarely, genetic disorders of the innate immune system, such as familial Mediterranean fever or cryopyrin-associated periodic syndromes, cause recurrent aseptic meningitis due to dysregulated cytokine production, particularly interleukin-1β.[19]

Histopathology

Histopathological features reflecting the underlying immune response can help distinguish aseptic meningitis from bacterial meningitis. The latter is typically characterized by predominant neutrophilic infiltration, and in some cases, identifiable bacteria may be demonstrated using special stains.[22][23][24]

• Lymphocytic infiltration: Typically perivascular and extending into the subarachnoid space, composed mainly of lymphocytes and occasionally monocytes. 
• Mild edema: Contributes to symptoms of increased intracranial pressure.
• Absence of pathogens: Histopathology does not reveal the presence of bacterial or fungal organisms, and viral particles are generally not detectable with routine staining techniques.
• Reactive changes: Hypertrophy and hyperplasia of meningeal and glial cells in response to inflammation.
• Vascular changes: Endothelial swelling and perivascular lymphocytic cuffing within small meningeal vessels.

Toxicokinetics

Toxicokinetics is not a primary concern in most cases of aseptic meningitis; it becomes relevant when the condition is drug-induced. Understanding the pharmacokinetics and potential for hypersensitivity reactions of the offending agent is essential for both management and prevention. Commonly implicated drugs include NSAIDs, antibiotics such as trimethoprim-sulfamethoxazole, and IVIG. The toxicokinetics of these drugs, including absorption, distribution, metabolism, and excretion, can influence the timing, onset, and severity of clinical symptoms.

History and Physical

No aspect of the clinical history possesses sufficient sensitivity or specificity to establish a definitive diagnosis of aseptic meningitis. Nonetheless, obtaining a detailed history is essential, given the broad range of possible etiologies. Key elements include exposure to sick contacts, recent travel, substance use, sexual history, preceding or concurrent infections, and recent medication use, particularly in the context of possible drug-induced aseptic meningitis.[2][4]

In general, patients present with an acute to subacute onset of headache, fever, neck stiffness, and photophobia, often with a more benign course than bacterial meningitis. Unlike bacterial meningitis, altered mental status is not a common feature.[2] Symptom profiles differ between adults and children. Adults often report headache, nausea, vomiting, malaise, weakness, stiff neck, and photophobia.[2][4] Children typically present with nonspecific symptoms, including fever, respiratory issues, rash, and irritability.[2][4] 

In neonates and infants younger than 3 months, signs may include a bulging anterior fontanelle and persistent irritability.[4] Specific risk factors, such as premature birth, maternal illness, elevated serum WBC count, hemoglobin levels below 10.7 mg/dL, and symptom onset within the first week of life, warrant urgent evaluation and management.[4][25] 

Neurological examination and vital sign findings in aseptic meningitis may include the following:[4][5]

• Nuchal rigidity: Stiffness or resistance to passive neck flexion, present in approximately 70% of cases.
• Fever: Reported in about 85% of patients.
• Kernig sign: Elicited with the patient supine and the hip and knee flexed to 90°; a positive sign is resistance or pain upon attempted knee extension. This sign is highly specific (95%) but has limited clinical utility due to low sensitivity (approximately 5%). 
• Brudzinski sign: Assessed by passively flexing the patient's neck while supine; a positive response is involuntary flexion of the hips and knees. 
• Encephalopathy: Less common, though some patients may present with confusion, disorientation, or lethargy.
• Rash: Less common, particularly in viral etiologies such as enteroviruses.  

Evaluation

Evaluation of aseptic meningitis can be challenging; however, advances in diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing, have facilitated the identification of pathogens. Progress has also been made in detecting autoimmune and paraneoplastic neurological syndromes, expanding the scope of recognized etiologies.[4] 

Notably, substantial differences exist between adults and children in both clinical presentation and laboratory findings.[2] These distinctions often necessitate age-specific diagnostic and therapeutic approaches, highlighting the importance of tailoring management strategies to different patient populations. 

Before performing a lumbar puncture, the clinical probability of elevated intracranial pressure should be assessed. If there is any suspicion of a space-occupying lesion or inflammation, a head computed tomography (CT) scan should be obtained before lumbar puncture, as recommended guidelines suggest.[5][26] In some cases, CT may also provide an alternative diagnosis, eliminating the need for a lumbar puncture.

In neonates and infants with open fontanelles, CT is typically unnecessary. Head ultrasound is the preferred imaging modality for this age group.[5][27] Research suggests that imaging can often be avoided if none of the following criteria are present:

• Age 60 or older
• History of CNS disease
• Immunocompromised state
• Altered mental state
• Seizure within 1 week of presentation
• Neurological deficits [4][5] 

These guidelines support evidence-based decision-making, ensuring that imaging resources are used appropriately and efficiently in patients suspected of having neurological conditions.  

Evaluation of aseptic meningitis follows a structured four-step approach:

• Clinical assessment, including a detailed history and physical examination
• Pre-lumbar puncture safety evaluation to assess contraindications
• Lumbar puncture and CSF analysis
• Microbiological and laboratory investigations to identify potential etiologies

Step 1: Clinical Assessment

• Obtain a detailed history [2]

  • Symptoms: Headache, fever, neck stiffness, photophobia, and rash 
  • Age-specific features

    • Children: Nonspecific symptoms
    • Neonates: Bulging fontanelle and irritability
  • Review any recent illness, travel history, sick contacts, or potential exposures
  • Medication history: Assess for drug-induced causes such as NSAIDs, antibiotics, IVIG, and monoclonal antibodies [4][5]

• Perform a physical and neurological examination, including:

  • Vital signs (fever)
  • Nuchal rigidity, Kernig, and Brudzinski signs
  • Rash (viral)
  • Mental status (usually preserved; encephalopathy is less common)

Step 2: Assess the safety of lumbar puncture

• Evaluate the risk of elevated intracranial pressure or a space-occupying lesion before lumbar puncture.[2][4][5]
• Risk factors include the following: 

  • Age 60 or older
  • History of CNS disease
  • Immunocompromised state
  • Altered mental status
  • Seizure within the past week
  • Focal neurological deficits

• If any risk factors are present, a head CT should be obtained before lumbar puncture
• In neonates or infants with an open fontanelle, a head ultrasound is performed instead of a CT

Step 3: Lumbar puncture and CSF analysis

• Opening pressure: Normal (<180 mm H₂O) or slightly elevated.
• Cell count with differential:

  • Lymphocytic pleocytosis (0-1000 WBC/μL).
  • Early neutrophil predominance (>50%), which later shifts to lymphocytes (>80%). 
  • Adults have higher CSF WBC and protein count.[5][2]
  • Children have more neutrophilic pleocytosis and higher leukocyte counts than adults.[5][2]
  • Neonates and young infants require age-adjusted values (approximately 57% of children with aseptic meningitis demonstrate a predominance of neutrophils in CSF).[5]

• Protein: Usually normal or mildly elevated (<200 mg/dL)
• Glucose: Typically normal

Step 4: Microbiological, molecular, and other testing 

• Gram stain and bacterial cultures to exclude bacterial meningitis
• PCR testing for viral pathogens:

  • Enterovirus (most common)
  • HSV-1 and HSV-2
  • VZV, cytomegalovirus, and EBV
  • Arboviruses

• Serum laboratories (see Table. Laboratory Evaluation for Aseptic Meningitis)

  • CBC with platelet count
  • Erythrocyte sedimentation rate
  • C-reactive protein
  • Procalcitonin
  • Syphilis serology 
  • Tuberculosis testing
  • Serum HIV testing
  • Immunoglobulin M and G for enterovirus, adenovirus, EBV, West Nile virus, and HSV.[4]
  • In immunocompromised patients, the diagnostic workup should be expanded to include fungal antibodies, mycobacterial studies, and less common viral pathogens.

• Blood cultures are used to rule out bacterial infections.
• Imaging: Magnetic resonance imaging or contrast-enhanced CT is indicated for patients with focal neurologic deficits, concern for complications, or to exclude alternative diagnoses.

Although distinguishing between aseptic and bacterial meningitis can be challenging, several diagnostic tools have been developed to support clinical decision-making. The Bacterial Meningitis Score remains the most specific tool currently available, with a sensitivity of 99% to 100% and a specificity of 52% to 62%. Additional laboratory findings, such as procalcitonin, C-reactive protein, and CSF basic profile, as well as CSF lactate levels, can provide valuable insights in differentiating bacterial from aseptic meningitis (see Table. Basic Profile of Cerebrospinal Fluid). 

The Nigrovic Rule is a validated bedside tool that is particularly useful in children.[28] This rule incorporates 5 criteria:

• Seizure at or before presentation
• Blood neutrophil count
• CSF Gram stain
• CSF protein
• CSF neutrophil count

The Nigorvic Rule demonstrates high sensitivity and serves as a practical guide for distinguishing bacterial from aseptic meningitis in pediatric populations.

Table

Table 1. Laboratory Evaluation for Aseptic Meningitis.

Abbreviations: ESR, erythrocyte sedimentation rate; HSV, herpes simplex virus; LCMV, lymphocytic choriomeningitis virus; PCR, polymerase chain reaction; CT, computed tomography; CSF, cerebrospinal fluid; FTA-ABS, fluorescent treponemal antibody absorption; ELISA, enzyme-linked immunosorbent assay; IgM, immunoglobulin M; MRI, magnetic resonance imaging; PPD, purified protein derivative.

 Table 2. Basic Profile of Cerebrospinal Fluid

Table

Treatment / Management

Early recognition of the likely cause of meningitis is vital for initiating timely treatment. The primary goal is clinical stabilization, and studies have demonstrated that administering intravenous (IV) fluids over 48 hours can yield measurable benefits.[5]

When bacterial or viral meningitis is suspected, empiric antimicrobial therapy should be started promptly. This therapy includes broad-spectrum antibiotics and antivirals such as acyclovir, selected according to the most likely pathogens for the patient's age group, which is particularly important in pediatric cases.[5] In immunocompromised individuals, who are at increased risk for opportunistic infections, antifungal therapy should also be considered. Ideally, CSF should be obtained before administering antibiotics; however, if this causes treatment delays or if the patient is critically ill, antibiotic therapy should not be postponed. A repeat lumbar puncture is typically unnecessary but may be indicated if the patient's clinical status fails to improve after 48 hours. Ongoing monitoring and reassessment of neurological status are crucial for guiding management and ensuring comprehensive, responsive care. 

Treatment should be individualized based on clinical suspicion and diagnostic findings. A summary of therapeutic approaches is provided in the table at the end (see Table. Key Aspects of Asceptic Meningitis Treatment).

Stabilization and Supportive Care

• Airway, breathing, and circulation: Stabilize immediately.[29]
• Neurological monitoring: Use the Glasgow Coma Scale and perform frequent serial mental status examinations (every 2-4 hours).
• Intravenous fluids: Administer as needed, especially in children, to reduce the risk of complications such as seizures and neurologic deficits.
• Antipyretics and analgesics: Provide for symptom control.
• Hospital admission: Recommended for children and for adults with significant symptoms or comorbidities.[2]

Empiric Therapy (Before Diagnosis Confirmed)

• Empiric antibiotics: Initiate in all patients with suspected meningitis until bacterial causes are excluded by CSF analysis.[2]
• Empiric acyclovir: Start if HSV or VZV is suspected, particularly in immunocompromised patients or those with encephalitic features.[3]
• Droplet isolation: Maintain for the first 24 hours if bacterial meningitis cannot be ruled out.[2]

Definitive Therapy (After Diagnosis Established)

• Viral (most common): Supportive care only; discontinue antibiotics. No specific therapy is required for most enteroviral cases.[2] Continue acyclovir if HSV or VZV is confirmed or strongly suspected.[5]
• Drug-induced or noninfectious: Discontinue the offending agent and provide supportive care.
• Fungal or other rare causes: Initiate pathogen-directed therapy as appropriate.

Steroids

• Dexamethasone is not routinely indicated for aseptic (viral) meningitis.
• Dexamethasone is used to treat bacterial meningitis, particularly when a pneumococcal infection is suspected.[5]
• Administer 10 to 20 minutes before or concurrently with antibiotics.
• Clinical trials have shown a benefit in reducing short-term neurologic sequelae and hearing loss associated with bacterial meningitis.[30]
• If steroids are started empirically and bacterial meningitis is ruled out, discontinue them.

Monitoring and Follow-Up

• Monitor closely for complications such as seizures, increased intracranial pressure, or neurologic deficits.
• Repeat lumbar puncture is rarely required unless the clinical course is atypical or the patient deteriorates.

Discharge 

• Discharge may be considered in patients with a benign course of aseptic meningitis. 
• Delay discharge for older patients, immunocompromised individuals, and children with pleocytosis.
• Provide home care instructions tailored to the underlying etiology (eg, strict hand hygiene and avoiding food sharing in enteroviral infections).[4][5] 

Table

Table 3. Key Aspects of Aseptic Meningitis Treatment.

Abbreviations: IV, intravenous; HSV, herpes simplex virus; VZV, varicella-zoster virus; CSF, cerebrospinal fluid.

Differential Diagnosis

The differential diagnosis of aseptic meningitis is broad, encompassing both infectious and noninfectious conditions. Clinical symptoms are often vague and nonspecific, which can significantly widen the range of possible diagnoses. Headache and fever are the most common presenting symptoms and play a central role in shaping the differential. Viral syndromes in particular may cause headache, myalgias, weakness, and fever—even in the absence of direct meningeal inflammation.[4][12] Similarly, systemic infections such as urinary tract infections and pneumonia can present with fever, headache, and generalized body aches. Consequently, a thorough evaluation for alternative infectious sources is an essential component of every diagnostic workup.[4][12]

Bacterial meningitis is the most concerning and prevalent alternative diagnosis and should be assumed until it is definitively excluded. Patients with compatible clinical features should also be evaluated for intracranial hemorrhage, particularly subarachnoid hemorrhage. The differential diagnosis further includes neoplastic disorders, such as leukemia and brain tumors; other types of headaches, such as migraines; and intracranial infections, including brain abscess and epidural abscess.[4][12] In addition, a wide range of systemic and environmental conditions, such as tuberculosis, tick-borne illnesses, carbon monoxide exposure, and even nonaccidental trauma in children, must be considered, underscoring the breadth of possibilities in the diagnostic process.[4][12]

The most critical distinction is between aseptic and bacterial meningitis, as bacterial meningitis requires urgent initiation of antibiotic therapy.[3][31] Partially treated bacterial meningitis, in which prior antibiotic exposure sterilizes CSF cultures, creates the false impression of aseptic meningitis. These cases must still be managed with a full course of antibiotics.[3] Other bacterial pathogens may cause subacute or atypical presentations, including M pneumoniae; spirochetes, such as Borrelia burgdorferi (Lyme disease), T pallidum (syphilis), and Leptospira species; and M tuberculosis and Brucella.

Beyond bacterial causes, fungal and parasitic infections can also present as aseptic meningitis, particularly in immunocompromised patients. Common culprits include Cryptococcus, Coccidioides, and T gondii.[3] Noninfectious etiologies further broaden the differential. Drug-induced aseptic meningitis may follow exposure to NSAIDs, IVIG, certain antibiotics, or vaccines.[3] Systemic illnesses, such as connective tissue diseases, notably systemic lupus erythematosus; vasculitides, for example, Kawasaki disease; sarcoidosis; and other granulomatous disorders, are also well-documented causes.[3] Neoplastic processes, including meningeal carcinomatosis or lymphoma with meningeal involvement, must also be considered.[3] Finally, other less common causes include postoperative or posttraumatic chemical meningitis.[3]

Prognosis

The prognosis of asceptic meningitis is generally favorable, with most patients, especially those with viral etiologies, achieving full recovery. Symptoms typically resolve within 5 to 14 days, and residual effects are typically mild, with fatigue and lightheadedness being the most common.[4] In contrast, prognosis is more guarded in cases related to neoplastic or autoimmune causes, immunocompromised individuals, or when complicated infections such as tuberculosis meningitis are involved. These scenarios carry a higher risk of morbidity and mortality if not promptly recognized and treated.[2][4]

Complications

The complications of aseptic meningitis are generally less severe compared to those associated with bacterial meningitis, but they can still occur, particularly in certain populations or with specific viral etiologies. Delays in treating suspected bacterial meningitis can result in permanent neurological sequelae, including hearing loss.[2][4] 

Viral meningitis may also be accompanied by encephalitis, resulting in a variable clinical presentation. For instance, mumps meningoencephalitis can lead to sensorineural deafness and aqueductal stenosis, the latter predisposing to hydrocephalus. Tuberculosis meningitis carries its own set of serious complications, including hydrocephalus, cerebral infarcts, epilepsy, mental regression, persistent neurological deficits, and cranial nerve palsies.[2][4] 

Neurological Complications

Seizures may occur, especially in children or when there is significant cerebral irritation, but prophylactic antiepileptics are not recommended in the absence of seizures.[4] Some patients experience transient cognitive or behavioral changes, such as confusion or irritability, during the acute phase of their illness. Rarely, mumps infection can lead to sensorineural hearing loss. Aseptic meningitis may also progress to encephalitis, particularly with enteroviruses, HSV, or arboviruses; HSV encephalitis can be severe and require urgent treatment. 

Chronic headaches are another possible complication, sometimes lasting weeks to months, but are typically resolved. Recurrent cases, such as Mollaret meningitis (recurrent HSV-2 meningitis), can also occur. 

Inflammation and obstruction of CSF pathways may result in hydrocephalus and increased intracranial pressure, causing headache, vomiting, and papilledema. Cranial nerve involvement may lead to temporary palsies, such as facial nerve palsy.

Systemic Complications

Although less common, systemic complications can develop. Enteroviral infections, for example, may lead to myocarditis or pericarditis. Arthritis or myositis may also occur in association with specific viral pathogens.

Complications in Immunocompromised Patients

Patients with weakened immune systems face a higher risk of severe complications. In this population, opportunistic infections are more frequent and outcomes are often worse, underscoring the importance of prompt recognition and targeted management. 

Management of Complications

Management of complications in aseptic meningitis depends on the specific clinical presentation. Seizures are treated with antiepileptic drugs as indicated, whereas headaches are generally managed with analgesics and adequate hydration; however, persistent or chronic headaches may warrant further evaluation. Hearing loss should be assessed with an audiologic evaluation, and intervention may be required if deficits are significant. Hydrocephalus, when symptomatic, may necessitate neurosurgical management. Cranial nerve palsies typically resolve spontaneously but may benefit from supportive care during the recovery process. 

Deterrence and Patient Education

Following initial diagnosis and treatment, the primary objective is to prevent the spread of highly infectious agents. Strict isolation protocols, including droplet precautions, along with hand hygiene, are crucial for limiting the transmission of viral meningitis and other infectious causes. Particular care is needed after diaper changes in children, as this is a common route of enterovirus infections.[2][4]

Proper hand hygiene is essential, and isolation measures should be tailored to the suspected infectious cause. Vaccination is a crucial preventive measure, with established vaccines protecting against polio, mumps, measles, rubella, and varicella, all of which should be administered according to recommended immunization schedules. Additionally, arboviral vaccines may be indicated for individuals residing in or traveling to endemic regions as a precautionary measure.[2][4][12]

Pearls and Other Issues

Key facts to keep in mind about aspectic meningitis include the following:

• Viral infection, particularly with enteroviruses, is considered the most common cause.
• HSV-2 can cause recurrent aseptic meningitis (Mollaret meningitis)
• Patients typically present with an acute onset of headache, fever, neck stiffness, and photophobia
• Altered mental status is uncommon and helps distinguish it from bacterial meningitis
• CSF fluid findings are normal or mildly elevated opening pressure, lymphocytic pleocytosis, normal glucose, and normal or mildly elevated protein
• Gram stain and bacterial cultures are negative
• Prognosis is generally good; most patients recover within 1 to 2 weeks
• Drug-induced aseptic meningitis can be caused by NSAIDs, trimethoprim-sulfamethoxazole, IVIG, and monoclonal antibodies
• Complications are rare but may include seizures, encephalitis, or chronic headaches
• Treatment is typically supportive, except for acyclovir for HSV or VZV, and pathogen-specific therapy for less common fungal or parasitic causes

Enhancing Healthcare Team Outcomes

Managing aseptic meningitis requires a team-based approach. Clinicians play a central role in diagnosis, relying on clinical symptoms and laboratory findings to guide treatment decisions, including the need for medications and hospitalization. Effective communication with patients and their families is crucial to ensure a clear understanding of the diagnosis, treatment plan, and expected outcomes. The primary focus of management is supportive care, accurate diagnosis, and appropriate medical therapy.

Specialist consultation may be warranted in complex cases. Infectious disease and neurology specialists can assist when severe neurological symptoms, complications, or specialized assessments are required. In contrast, oncology involvement may be appropriate if meningitis arises as a secondary complication of malignancy.

Because meningitis is a potentially dangerous infectious disease, communication with all members of the healthcare team is essential. Strict adherence to isolation protocols and the use of personal protective equipment are crucial in preventing the transmission of infection to staff and other patients. Once the diagnosis of aseptic meningitis is confirmed and more concerning infectious causes have been excluded, these precautions can be safely discontinued.[2][4]

A lumbar puncture is necessary to confirm the diagnosis of aseptic meningitis. An emergency medicine clinician, an internist in the inpatient setting, or an interventional radiologist may perform a lumbar puncture. Laboratory expertise is essential for analyzing specimens and conducting PCR studies, which help identify the underlying etiology—most often viral. Despite their utility, these molecular studies remain underused in practice.[2][4][5] 

Nurses play a vital role by closely monitoring patients, tracking vital signs, and assessing neurological status, which enables the early recognition of complications or clinical deterioration. Pharmacists contribute by ensuring appropriate medication dosing, checking for drug interactions, and verifying compatibility of therapies prescribed for aseptic meningitis.

Regular interprofessional team meetings facilitate collaboration by allowing discussion of patient progress, adjustments to the treatment plan, and addressing any challenges faced by the healthcare team.[2][4][5][12] Coordination between hospital and community-based care ensures a seamless patient transition, reducing the risk of missed follow-up appointments and lapses in medication adherence.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Tattevin P, Tchamgoué S, Belem A, Bénézit F, Pronier C, Revest M. Aseptic meningitis. Rev Neurol (Paris). 2019 Sep-Oct;175(7-8):475-480. [PubMed: 31375286]

2.

Shukla B, Aguilera EA, Salazar L, Wootton SH, Kaewpoowat Q, Hasbun R. Aseptic meningitis in adults and children: Diagnostic and management challenges. J Clin Virol. 2017 Sep;94:110-114. [PMC free article: PMC5581214] [PubMed: 28806629]

3.

Irani DN. Aseptic meningitis and viral myelitis. Neurol Clin. 2008 Aug;26(3):635-55, vii-viii. [PMC free article: PMC2728900] [PubMed: 18657719]

4.

Kumar R. Aseptic meningitis: diagnosis and management. Indian J Pediatr. 2005 Jan;72(1):57-63. [PubMed: 15684450]

5.

Putz K, Hayani K, Zar FA. Meningitis. Prim Care. 2013 Sep;40(3):707-26. [PubMed: 23958365]

6.

Parasuraman TV, Frenia K, Romero J. Enteroviral meningitis. Cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics. 2001 Jan;19(1):3-12. [PubMed: 11252544]

7.

Jha P, Stromich J, Cohen M, Wainaina JN. A Rare Complication of Trimethoprim-Sulfamethoxazole: Drug Induced Aseptic Meningitis. Case Rep Infect Dis. 2016;2016:3879406. [PMC free article: PMC4992527] [PubMed: 27579194]

8.

Jarrin I, Sellier P, Lopes A, Morgand M, Makovec T, Delcey V, Champion K, Simoneau G, Green A, Mouly S, Bergmann JF, Lloret-Linares C. Etiologies and Management of Aseptic Meningitis in Patients Admitted to an Internal Medicine Department. Medicine (Baltimore). 2016 Jan;95(2):e2372. [PMC free article: PMC4718237] [PubMed: 26765411]

9.

Song P, Seok JM, Kim S, Choi J, Bae JY, Yu SN, Park J, Choi K, Yang Y, Jeong D, Yang KI, Park H. Viral Etiology of Aseptic Meningitis and Clinical Prediction of Herpes Simplex Virus Type 2 Meningitis. J Pers Med. 2024 Sep 20;14(9) [PMC free article: PMC11433182] [PubMed: 39338252]

10.

Aldriweesh MA, Shafaay EA, Alwatban SM, Alkethami OM, Aljuraisi FN, Bosaeed M, Alharbi NK. Viruses Causing Aseptic Meningitis: A Tertiary Medical Center Experience With a Multiplex PCR Assay. Front Neurol. 2020;11:602267. [PMC free article: PMC7793969] [PubMed: 33424752]

11.

Han SH, Choi HY, Kim JM, Park KR, Youn YC, Shin HW. Etiology of aseptic meningitis and clinical characteristics in immune-competent adults. J Med Virol. 2016 Jan;88(1):175-9. [PubMed: 26118835]

12.

Mount HR, Boyle SD. Aseptic and Bacterial Meningitis: Evaluation, Treatment, and Prevention. Am Fam Physician. 2017 Sep 01;96(5):314-322. [PubMed: 28925647]

13.

Mamishi S, Sarkardeh M, Pourakbari B, Keshavarz Valian S, Sabouni F, Mahmoudi S. Aseptic meningitis after measles-mumps-rubella (MMR) vaccination. Br J Biomed Sci. 2016;73(2):84-6. [PubMed: 27181175]

14.

Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, Barreto ML. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. Am J Epidemiol. 2000 Mar 01;151(5):524-30. [PubMed: 10707922]

15.

Jorquera L A, Ugarte C D, Avilés L C, Delpiano M L. [Aseptic meningitis due to mumps vaccine. Case report and review of the literature]. Rev Chilena Infectol. 2020 Dec;37(6):769-774. [PubMed: 33844819]

16.

Riordan A, Ladhani SN. Aseptic meningitis associated with routine infant immunisation visits that include the group B meningococcal vaccine, 4CMenB. Arch Dis Child. 2019 Dec;104(12):1237-1238. [PubMed: 31422348]

17.

McBride M, Williman J, Best E, Walls T, Sadarangani M, Grant CC, Martin NG. The epidemiology of aseptic meningitis in New Zealand children from 1991 to 2020. J Paediatr Child Health. 2022 Nov;58(11):1980-1989. [PMC free article: PMC9796418] [PubMed: 35861029]

18.

Lee KY, Burgner D, Lee HS, Hong JH, Lee MH, Kang JH, Lee BC. The changing epidemiology of pediatric aseptic meningitis in Daejeon, Korea from 1987 to 2003. BMC Infect Dis. 2005 Nov 02;5:97. [PMC free article: PMC1295587] [PubMed: 16262909]

19.

Neokleous A, Psarelis S, Parperis KM. Aseptic Μeningitis in Hereditary Autoinflammatory Diseases. Cureus. 2020 May 22;12(5):e8244. [PMC free article: PMC7398045] [PubMed: 32765981]

20.

Nannini S, Koshenkova L, Baloglu S, Chaussemy D, Noël G, Schott R. Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review. J Neurooncol. 2022 May;157(3):533-550. [PMC free article: PMC9458695] [PubMed: 35416575]

21.

Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P. Drug-induced aseptic meningitis: a mini-review. Fundam Clin Pharmacol. 2018 Jun;32(3):252-260. [PubMed: 29364542]

22.

Khishfe BF, Krass LM, Nordquist EK. Kikuchi disease presenting with aseptic meningitis. Am J Emerg Med. 2014 Oct;32(10):1298.e1-2. [PubMed: 24746858]

23.

Berg AM, Kasznica J, Hopkins P, Simms RW. Relapsing polychondritis and aseptic meningitis. J Rheumatol. 1996 Mar;23(3):567-9. [PubMed: 8833007]

24.

O'Sullivan SS, O'Connell B, Redmond J. Aseptic meningitis: a 2-year review of diagnoses reached in a tertiary neurological and infectious disease centre. Ir J Med Sci. 2007 Sep;176(3):215-9. [PubMed: 17659429]

25.

Chen W, Dai S, Xu L. Clinical characterization of benign enterovirus infection in neonates. Medicine (Baltimore). 2021 May 07;100(18):e25706. [PMC free article: PMC8104291] [PubMed: 33950953]

26.

Salazar L, Hasbun R. Cranial Imaging Before Lumbar Puncture in Adults With Community-Acquired Meningitis: Clinical Utility and Adherence to the Infectious Diseases Society of America Guidelines. Clin Infect Dis. 2017 Jun 15;64(12):1657-1662. [PMC free article: PMC5850549] [PubMed: 28369295]

27.

Yoon HK, Cho SW. Neonatal head ultrasound: systematic approach to congenital Central Nervous System anomalies. A pictorial essay. Med Ultrason. 2016 Sep;18(3):386-93. [PubMed: 27622417]

28.

Dubos F, Lamotte B, Bibi-Triki F, Moulin F, Raymond J, Gendrel D, Bréart G, Chalumeau M. Clinical decision rules to distinguish between bacterial and aseptic meningitis. Arch Dis Child. 2006 Aug;91(8):647-50. [PMC free article: PMC2083061] [PubMed: 16595647]

29.

Carter E, McGill F. The management of acute meningitis: an update. Clin Med (Lond). 2022 Sep;22(5):396-400. [PMC free article: PMC9594998] [PubMed: 36507811]

30.

Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS. Corticosteroids and mortality in children with bacterial meningitis. JAMA. 2008 May 07;299(17):2048-55. [PubMed: 18460665]

31.

Coyle PK. Overview of acute and chronic meningitis. Neurol Clin. 1999 Nov;17(4):691-710. [PMC free article: PMC7132757] [PubMed: 10517924]

Disclosure: Franklyn Rocha Cabrero declares no relevant financial relationships with ineligible companies.

Disclosure: Elodie Betances declares no relevant financial relationships with ineligible companies.

Disclosure: Thomas Perera declares no relevant financial relationships with ineligible companies.